• 1.河北北方學(xué)院(河北張家口 075000);;
  • 2.解放軍第251醫(yī)院普外科(河北張家口 075000);

目的介紹連環(huán)蛋白家族新成員p120-連環(huán)蛋白(p120-catenin，p120ctn)及其在腫瘤研究中的進展。方法查閱近年來國內(nèi)、外有關(guān)對p120ctn研究的文獻并作綜述。結(jié)果①p120ctn參與鈣黏蛋白連環(huán)蛋白復(fù)合體的形成，參與細胞生長、增殖和黏附連接; ②調(diào)控Rho GTP 酶的活性，促進細胞運動性; ③與核內(nèi)轉(zhuǎn)錄因子Kaiso結(jié)合形成Kaiso-p120ctn復(fù)合體，參與基因轉(zhuǎn)錄的調(diào)控; ④參與血管內(nèi)皮生長因子誘導(dǎo)的血管新生過程; ⑤參與炎癥、細胞惡變以及腫瘤侵襲、轉(zhuǎn)移過程。結(jié)論p120ctn作為連環(huán)蛋白家族中的一個新成員，依靠它的細胞定位參與多種生物過程，從分子水平深入了解p120ctn的生物學(xué)功能及作用機理，有利于從p120ctn的異常改變判斷腫瘤的發(fā)生和發(fā)展，為腫瘤的預(yù)防和治療提供新的手段。

引用本文： 南潤玲,尚培中. 連環(huán)蛋白家族的新成員——p120-連環(huán)蛋白. 中國普外基礎(chǔ)與臨床雜志, 2011, 18(4): 462-467. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Cheung LW, Leung PC, Wong AS. Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropinreleasing hormone to promote tumor cell migration and invasion in ovarian cancer [J]. Oncogene, 2010, 29(16): 24272440.
2. Albert B, Reynolds AB. p120catenin: Past and present [J]. Biochim Biophys Acta, 2007, 1773(1): 27.
3. 歐海玲, 覃宇周, 張錫流. Ecadherin/p120ctn與腫瘤關(guān)系的研究進展 [J]. 中國臨床新醫(yī)學(xué), 2009, 2(2): 201205.
4. Hatzfel DM. The p120 family of cell adhesion molecules [J]. Eur J Cell Biol, 2005, 84(23): 205214.
5. Grossmann KS, Grund C, Huelsken J, et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation [J]. J Cell Biol, 2004, 167(1): 149160.
6. Ishiyama N, Lee SH, Liu S, et al. Dynamic and static interactions between p120 catenin and Ecadherin regulate the stability of cellcell adhesion [J]. Cell, 2010, 141(1): 117128.
7. Xiao K, Oas RG, Chiasson CM, et al. Role of p120catenin in cadherin trafficking [J]. Biochim Biophys Acta, 2007, 1773(1): 816.
8. SmalleyFreed WG, Efimov A, Burnett PE, et al. p120catenin is essential for maintenance of barrier function and intestinal homeostasis in mice [J]. J Clin Invest, 2010, 120(6): 18241835.
9. Ichii T, Takeichi M. p120catenin regulates microtubule dynamics and cell migration in a cadherinindependent manner [J]. Genes Cells, 2007, 12(7): 827839.
10. Anastasiadis PZ. p120ctn: A nexus for contextual signaling via Rho GTPases [J]. Biochim Biophys Acta, 2007, 1773(1): 3446.
11. Kolanus W, Zeitlmann L. Regulation of integrin function by insideout signaling mechanisms [J]. Curr Top Microbiol Immunol, 1998, 231: 3349.
12. Fukumoto Y, Shintani Y, Reynolds AB, et al. The regulatory or phosphorylation domain of p120 catenin controls Ecadherin dynamics at the plasma membrane [J]. Exp Cell Res, 2008, 314(1): 5267.
13. Brown MV, Burnett PE, Denning MF, et al. PDGF receptor activation induces p120catenin phosphorylation at serine 879 via a PKCalphadependent pathway [J]. Exp Cell Res, 2009, 315(1): 3949.
14. Soto E, Yanagisawa M, Marlow LA, et al. p120 catenin induces opposing effects on tumor cell growth depending on Ecadherin expression [J]. J Cell Biol, 2008, 183(4): 737749.
15. Zhang J, O’Donnell JJ 3rd, Holian O, et al. P120 catenin represses transcriptional activity through Kaiso in endothelial cells [J]. Microvasc Res, 2010, 80(2): 233239.
16. Fukuyama T, Ogita H, Kawakatsu T, et al. Activation of Rac by cadherin through the cSrcRap1phosphatidylinositol 3kinaseVav2 pathway [J]. Oncogene, 2006, 25(1): 819.
17. Daniel JM. Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso [J]. Biochim Biophys Acta, 2007, 1773(1): 5968.
18. Park JI, Kim SW, Lyons JP, et al. Kaiso/p120catenin and TCF/betacatenin complexes coordinately regulate canonical Wnt gene targets [J]. Dev Cell, 2005, 8(6): 843854.
19. Dai SD, Wang Y, Jiang GY, et al. Kaiso is expressed in lung cancer: its expression and localization is affected by p120ctn [J]. Lung Cancer, 2010, 67(2): 205215.
20. 羅小華, 劉文勵. P120ctn在血管內(nèi)皮生長因子誘導(dǎo)血管生成中的作用 [J]. 臨床血液學(xué)雜志, 2006, 19(1): 5456.
21. Oas RG, Xiao K, Summers S, et al. p120Catenin is required for mouse vascular development [J]. Circ Res, 2010, 106(5): 941951.
22. Esser S, Lampugnani MG, Corada M, et al. Vascular endothelial growth factor induces VEcadherin tyrosine phosphorylation in endothelial cells [J]. J Cell Sci, 1998, 111(Pt 13): 18531865.
23. van Hengel J, van Roy F. Diverse functions of p120ctn in tumors [J]. Biochim Biophys Acta, 2007, 1773(1): 7888.
24. 黃華藝, 農(nóng)朝贊, 郭凌宵, 等. 肝癌細胞生物學(xué)行為改變涉及p120ctn酪氨酸磷酸化的研究 [J]. 中華醫(yī)學(xué)雜志, 2003, 83(20): 18011806.
25. Nong CZ, Pan LL, He WS, et al. P120ctn overexpression enhances beta catenin Ecadherin binding and down regulates expression of survivin and cyclin D1 in BEL7404 hepatoma cells [J]. World J Gastroenterol, 2006, 12(8): 11871191.
26. 農(nóng)朝贊, 黃嬋娟, 潘莉莉, 等. β連環(huán)蛋白在轉(zhuǎn)染p120ctn同工蛋白3A的肝癌細胞中的表達變化 [J]. 臨床與實驗病理學(xué)雜志, 2008, 24(6): 712715.
27. Zhai B, Yan HX, Liu SQ, et al. Reduced expression of Ecadherin/catenin complex in hepatocellular carcinomas [J]. World J Gastroenterol, 2008, 14(37): 56655673.
28. 張毅, 朱瑾, 楊占宇, 等. 連環(huán)蛋白P120在肝細胞癌中的表達及其意義 [J]. 消化外科, 2006, 5(6): 431434.
29. Karatzas G, Karayiannakis AJ, Syrigos KN, et al. Expression patterns of the Ecadherincatenin cellcell adhesion complex in gastric cancer [J]. Hepatogastroenterology, 2000, 47(35): 14651469.
30. Ogden SR, Wroblewski LE, Weydig C, et al. p120 and Kaiso regulate Helicobacter pyloriinduced expression of matrix metalloproteinase [J]. Mol Biol Cell, 2008,19(10): 41104121.
31. Jawhari AU, Noda M, Pignatelli M, et al. Upregulated cytoplasmic expression, with reduced membranous distribution, of the srcsubstrate p120 (ctn) in gastric carcinoma [J]. J Pathol, 1999, 189(2): 180185.
32. 虞志強. CDX2和p120catenin在胃癌組織中的臨床意義 [J]. 實用癌癥雜志, 2009, 24(6): 573575.
33. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer [J]. Biochim Biophys Acta, 2003, 1653(1): 124.
34. 戴越盟, 嚴律南. β連環(huán)蛋白及APC基因與腫瘤 [J]. 中國普外基礎(chǔ)與臨床雜志, 2002, 9(4): 291292.
35. Yanagisawa M, Huveldt D, Kreinest P, et al. A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease [J]. J Biol Chem, 2008, 283(26): 1834418354.
36. 李景南, 李瀟, 錢家鳴, 等. Kras基因突變通過調(diào)節(jié)Ecadherin/βcatenin/p120蛋白復(fù)合體形成和RhoA蛋白活性對結(jié)腸癌細胞株Caco2轉(zhuǎn)移的影響 [J]. 中國醫(yī)學(xué)科學(xué)院學(xué)報, 2010, 32(1): 4650.
37. Bellovin DI, Bates RC, Muzikansky A, et al. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease [J]. Cancer Res, 2005, 65(23): 1093810945.
38. Verschuur EM, Siersema PD. Diagnostics and treatment of esophageal cancers [J]. Ned Tijdschr Tandheelkd, 2010, 117(9): 427431.
39. Ma J, Zhang J, Ma Y, et al. Adenovirusmediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo [J]. Med Oncol, 2010, [Epub ahead of print].
40. Chung Y, Lam AK, Luk JM, et al. Altered Ecadherin expression and p120 catenin localization in esophageal squamous cell carcinoma [J]. Ann Surg Oncol, 2007, 14(11): 32603267.
41. Wijnhoven BP, Pignatelli M, Dinjens WN, et al. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction [J]. J Surg Oncol, 2005, 92(2): 116123.
42. Miao Y, Liu N, Zhang Y, et al. p120ctn isoform 1 expression significantly correlates with abnormal expression of Ecadherin and poor survival of lung cancer patients [J]. Med Oncol, 2010, 27(3): 880886.
43. Dai SD, Zhang XW, Qi FJ, et al. Expression of Ecadherin, betacatenin and p120ctn in the pulmonary sclerosing hemangioma [J]. Lung Cancer, 2007, 57(1): 5459.
44. Wang EH, Liu Y, Xu HT, et al. Abnormal expression and clinicopathologic significance of p120catenin in lung cancer [J]. Histol Histopathol, 2006, 21(8): 841847.
45. Liu Y, Wang Y, Zhang Y, et al. Abnormal expression of p120catenin, Ecadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer [J]. Lung Cancer, 2009, 63(3): 375382.
46. 苗原, 劉洋, 王妍, 等. p120ctn亞型在肺鱗癌、腺癌中表達及意義 [J]. 中國肺癌雜志, 2008, 11(2): 189193.
47. Chu EA, Wu JM, Tunkel DE, et al. Nasopharyngeal carcinoma: the role of the EpsteinBarr virus [J]. Medscape J Med, 2008, 10(7): 165.
48. Dittmer DP, Hilscher CJ, Gulley ML, et al. Multiple pathways for EpsteinBarr virus episome loss from nasopharyngeal carcinoma [J]. Int J Cancer, 2008, 123(9): 21052112.
49. 游淑源, 韓安家, 張芬芬, 等. 鼻咽癌中EB病毒編碼的潛伏膜蛋白1對βcatenin轉(zhuǎn)錄活性及表達的影響 [J]. 中華病理學(xué)雜志, 2010, 39(8): 537541.
50. 葉輝信, 張錫流, 歐海燕, 等. 上皮鈣黏蛋白和連環(huán)蛋白120在鼻咽癌組織中的表達及相關(guān)性研究 [J]. 臨床耳鼻咽喉頭頸外科雜志, 2009, 23(14): 646648.
51. 歐海玲, 覃宇周, 張錫流, 等. P120連環(huán)蛋白在鼻咽癌中的表達及其與細胞凋亡的關(guān)系 [J]. 實用醫(yī)學(xué)雜志, 2009, 25(22): 37493752.
52. Zhang X, Disanto ME. Rhokinase, a common final path of various contractile bladder and ureter stimuli [J]. Handb Exp Pharmacol, 2011, (202): 543568.
53. Mandeville JA, Silva Neto B, Vanni AJ, et al. Pcadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells [J]. BJU Int, 2008, 2(11): 17071714.
54. 林成楚, 許恩賜. 膀胱移行細胞癌中p120ctn的表達及意義 [J]. 山東醫(yī)藥, 2008, 48(30): 3637.
55. Silva Neto B, Smith GL, Mandeville JA, et al. Prognostic significance of altered p120 ctn expression in bladder cancer [J]. BJU Int, 2008, 101(6): 746752.
56. 張錫流, 何仕遠, 張力, 等． E鈣黏附蛋白及其相關(guān)蛋白在前列腺癌組織中的表達及其臨床意義 [J]. 檢驗醫(yī)學(xué), 2006, 21(1): 57.
57. Kaulfuss S, von Hardenberg S, Schweyer S, et al. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression [J]. Oncogene, 2009, 28(45): 39713982.
58. van Oort IM, Tomita K, van Bokhoven A, et al. The prognostic value of Ecadherin and the cadherinassociated molecules alpha, beta, gammacatenin and p120ctn in prostate cancer specific survival: a longterm followup study [J]. Prostate, 2007, 67(13): 14321438.
59. Kallakury BV, Sheehan CE, WinnDeen E, et al. Decreased expression of catenins (alpha and beta), p120 CTN, and Ecadherin cell adhesion proteins and Ecadherin gene promoter methylation in prostatic adenocarcinomas [J]. Cancer, 2001, 92(11): 27862795.
60. Freeman JW, McGrath P, Bondada V, et al. Prognostic significance of proliferation associated nucleolar antigen p120 in human breast carcinoma [J].Cancer Res, 1991, 51(8): 19731978.
61. Paredes J, Correia AL, Ribeiro AS, et al. Expression of p120catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines [J]. Cell Oncol, 2007, 29(6): 467476.
62. Sarrió D, PérezMies B, Hardisson D, et al. Cytoplasmic localization of p120ctn and Ecadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions [J]. Oncogene, 2004, 23(19): 32723283.
63. Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin [J]. Am J Surg Pathol, 2007, 31(3): 427437.
64. 李曉鳴, 溫漓潮, 朱任之. 乳腺典型髓樣癌與非典型髓樣癌生物學(xué)行為差異的研究 [J]. 中國普外基礎(chǔ)與臨床雜志, 2003, 10(3): 268269.
65. Boriani S, Bandiera S, Biagini R, et al. Chordoma of the mobilesp ine: fifty years of experience [J]. Spine (Phila Pa 1976), 2006, 31(4): 493503.
66. Guirat A, Affes N, Boujlbene S, et al. Sacral chordoma: a rare tumor of the buttocks [J]. Ann Dermatol Venereol, 2009, 136(67): 526529.
67. Schwab JH, Boland PJ, Agaram NP, et al. Chordoma and chondrosarcoma gene profile: implications for immunotherapy [J]. Cancer Immunol Immunother, 2009, 58(3): 339349.
68. 馬俊明, 楊興海, 黃權(quán), 等. Ecadherin和P120ctn在脊柱脊索瘤中的異常表達 [J]. 脊柱外科雜志, 2009, 7(4): 193197.
69. Chartier NT, Oddou CI, Lainé MG, et al. Cyclindependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)dependent cell growth control: a new role for p120ctn in cancer [J]. Cancer Res, 2007, 67(20): 97819790.
  1. 1. Cheung LW, Leung PC, Wong AS. Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropinreleasing hormone to promote tumor cell migration and invasion in ovarian cancer [J]. Oncogene, 2010, 29(16): 24272440.
  2. 2. Albert B, Reynolds AB. p120catenin: Past and present [J]. Biochim Biophys Acta, 2007, 1773(1): 27.
  3. 3. 歐海玲, 覃宇周, 張錫流. Ecadherin/p120ctn與腫瘤關(guān)系的研究進展 [J]. 中國臨床新醫(yī)學(xué), 2009, 2(2): 201205.
  4. 4. Hatzfel DM. The p120 family of cell adhesion molecules [J]. Eur J Cell Biol, 2005, 84(23): 205214.
  5. 5. Grossmann KS, Grund C, Huelsken J, et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation [J]. J Cell Biol, 2004, 167(1): 149160.
  6. 6. Ishiyama N, Lee SH, Liu S, et al. Dynamic and static interactions between p120 catenin and Ecadherin regulate the stability of cellcell adhesion [J]. Cell, 2010, 141(1): 117128.
  7. 7. Xiao K, Oas RG, Chiasson CM, et al. Role of p120catenin in cadherin trafficking [J]. Biochim Biophys Acta, 2007, 1773(1): 816.
  8. 8. SmalleyFreed WG, Efimov A, Burnett PE, et al. p120catenin is essential for maintenance of barrier function and intestinal homeostasis in mice [J]. J Clin Invest, 2010, 120(6): 18241835.
  9. 9. Ichii T, Takeichi M. p120catenin regulates microtubule dynamics and cell migration in a cadherinindependent manner [J]. Genes Cells, 2007, 12(7): 827839.
  10. 10. Anastasiadis PZ. p120ctn: A nexus for contextual signaling via Rho GTPases [J]. Biochim Biophys Acta, 2007, 1773(1): 3446.
  11. 11. Kolanus W, Zeitlmann L. Regulation of integrin function by insideout signaling mechanisms [J]. Curr Top Microbiol Immunol, 1998, 231: 3349.
  12. 12. Fukumoto Y, Shintani Y, Reynolds AB, et al. The regulatory or phosphorylation domain of p120 catenin controls Ecadherin dynamics at the plasma membrane [J]. Exp Cell Res, 2008, 314(1): 5267.
  13. 13. Brown MV, Burnett PE, Denning MF, et al. PDGF receptor activation induces p120catenin phosphorylation at serine 879 via a PKCalphadependent pathway [J]. Exp Cell Res, 2009, 315(1): 3949.
  14. 14. Soto E, Yanagisawa M, Marlow LA, et al. p120 catenin induces opposing effects on tumor cell growth depending on Ecadherin expression [J]. J Cell Biol, 2008, 183(4): 737749.
  15. 15. Zhang J, O’Donnell JJ 3rd, Holian O, et al. P120 catenin represses transcriptional activity through Kaiso in endothelial cells [J]. Microvasc Res, 2010, 80(2): 233239.
  16. 16. Fukuyama T, Ogita H, Kawakatsu T, et al. Activation of Rac by cadherin through the cSrcRap1phosphatidylinositol 3kinaseVav2 pathway [J]. Oncogene, 2006, 25(1): 819.
  17. 17. Daniel JM. Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso [J]. Biochim Biophys Acta, 2007, 1773(1): 5968.
  18. 18. Park JI, Kim SW, Lyons JP, et al. Kaiso/p120catenin and TCF/betacatenin complexes coordinately regulate canonical Wnt gene targets [J]. Dev Cell, 2005, 8(6): 843854.
  19. 19. Dai SD, Wang Y, Jiang GY, et al. Kaiso is expressed in lung cancer: its expression and localization is affected by p120ctn [J]. Lung Cancer, 2010, 67(2): 205215.
  20. 20. 羅小華, 劉文勵. P120ctn在血管內(nèi)皮生長因子誘導(dǎo)血管生成中的作用 [J]. 臨床血液學(xué)雜志, 2006, 19(1): 5456.
  21. 21. Oas RG, Xiao K, Summers S, et al. p120Catenin is required for mouse vascular development [J]. Circ Res, 2010, 106(5): 941951.
  22. 22. Esser S, Lampugnani MG, Corada M, et al. Vascular endothelial growth factor induces VEcadherin tyrosine phosphorylation in endothelial cells [J]. J Cell Sci, 1998, 111(Pt 13): 18531865.
  23. 23. van Hengel J, van Roy F. Diverse functions of p120ctn in tumors [J]. Biochim Biophys Acta, 2007, 1773(1): 7888.
  24. 24. 黃華藝, 農(nóng)朝贊, 郭凌宵, 等. 肝癌細胞生物學(xué)行為改變涉及p120ctn酪氨酸磷酸化的研究 [J]. 中華醫(yī)學(xué)雜志, 2003, 83(20): 18011806.
  25. 25. Nong CZ, Pan LL, He WS, et al. P120ctn overexpression enhances beta catenin Ecadherin binding and down regulates expression of survivin and cyclin D1 in BEL7404 hepatoma cells [J]. World J Gastroenterol, 2006, 12(8): 11871191.
  26. 26. 農(nóng)朝贊, 黃嬋娟, 潘莉莉, 等. β連環(huán)蛋白在轉(zhuǎn)染p120ctn同工蛋白3A的肝癌細胞中的表達變化 [J]. 臨床與實驗病理學(xué)雜志, 2008, 24(6): 712715.
  27. 27. Zhai B, Yan HX, Liu SQ, et al. Reduced expression of Ecadherin/catenin complex in hepatocellular carcinomas [J]. World J Gastroenterol, 2008, 14(37): 56655673.
  28. 28. 張毅, 朱瑾, 楊占宇, 等. 連環(huán)蛋白P120在肝細胞癌中的表達及其意義 [J]. 消化外科, 2006, 5(6): 431434.
  29. 29. Karatzas G, Karayiannakis AJ, Syrigos KN, et al. Expression patterns of the Ecadherincatenin cellcell adhesion complex in gastric cancer [J]. Hepatogastroenterology, 2000, 47(35): 14651469.
  30. 30. Ogden SR, Wroblewski LE, Weydig C, et al. p120 and Kaiso regulate Helicobacter pyloriinduced expression of matrix metalloproteinase [J]. Mol Biol Cell, 2008,19(10): 41104121.
  31. 31. Jawhari AU, Noda M, Pignatelli M, et al. Upregulated cytoplasmic expression, with reduced membranous distribution, of the srcsubstrate p120 (ctn) in gastric carcinoma [J]. J Pathol, 1999, 189(2): 180185.
  32. 32. 虞志強. CDX2和p120catenin在胃癌組織中的臨床意義 [J]. 實用癌癥雜志, 2009, 24(6): 573575.
  33. 33. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer [J]. Biochim Biophys Acta, 2003, 1653(1): 124.
  34. 34. 戴越盟, 嚴律南. β連環(huán)蛋白及APC基因與腫瘤 [J]. 中國普外基礎(chǔ)與臨床雜志, 2002, 9(4): 291292.
  35. 35. Yanagisawa M, Huveldt D, Kreinest P, et al. A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease [J]. J Biol Chem, 2008, 283(26): 1834418354.
  36. 36. 李景南, 李瀟, 錢家鳴, 等. Kras基因突變通過調(diào)節(jié)Ecadherin/βcatenin/p120蛋白復(fù)合體形成和RhoA蛋白活性對結(jié)腸癌細胞株Caco2轉(zhuǎn)移的影響 [J]. 中國醫(yī)學(xué)科學(xué)院學(xué)報, 2010, 32(1): 4650.
  37. 37. Bellovin DI, Bates RC, Muzikansky A, et al. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease [J]. Cancer Res, 2005, 65(23): 1093810945.
  38. 38. Verschuur EM, Siersema PD. Diagnostics and treatment of esophageal cancers [J]. Ned Tijdschr Tandheelkd, 2010, 117(9): 427431.
  39. 39. Ma J, Zhang J, Ma Y, et al. Adenovirusmediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo [J]. Med Oncol, 2010, [Epub ahead of print].
  40. 40. Chung Y, Lam AK, Luk JM, et al. Altered Ecadherin expression and p120 catenin localization in esophageal squamous cell carcinoma [J]. Ann Surg Oncol, 2007, 14(11): 32603267.
  41. 41. Wijnhoven BP, Pignatelli M, Dinjens WN, et al. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction [J]. J Surg Oncol, 2005, 92(2): 116123.
  42. 42. Miao Y, Liu N, Zhang Y, et al. p120ctn isoform 1 expression significantly correlates with abnormal expression of Ecadherin and poor survival of lung cancer patients [J]. Med Oncol, 2010, 27(3): 880886.
  43. 43. Dai SD, Zhang XW, Qi FJ, et al. Expression of Ecadherin, betacatenin and p120ctn in the pulmonary sclerosing hemangioma [J]. Lung Cancer, 2007, 57(1): 5459.
  44. 44. Wang EH, Liu Y, Xu HT, et al. Abnormal expression and clinicopathologic significance of p120catenin in lung cancer [J]. Histol Histopathol, 2006, 21(8): 841847.
  45. 45. Liu Y, Wang Y, Zhang Y, et al. Abnormal expression of p120catenin, Ecadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer [J]. Lung Cancer, 2009, 63(3): 375382.
  46. 46. 苗原, 劉洋, 王妍, 等. p120ctn亞型在肺鱗癌、腺癌中表達及意義 [J]. 中國肺癌雜志, 2008, 11(2): 189193.
  47. 47. Chu EA, Wu JM, Tunkel DE, et al. Nasopharyngeal carcinoma: the role of the EpsteinBarr virus [J]. Medscape J Med, 2008, 10(7): 165.
  48. 48. Dittmer DP, Hilscher CJ, Gulley ML, et al. Multiple pathways for EpsteinBarr virus episome loss from nasopharyngeal carcinoma [J]. Int J Cancer, 2008, 123(9): 21052112.
  49. 49. 游淑源, 韓安家, 張芬芬, 等. 鼻咽癌中EB病毒編碼的潛伏膜蛋白1對βcatenin轉(zhuǎn)錄活性及表達的影響 [J]. 中華病理學(xué)雜志, 2010, 39(8): 537541.
  50. 50. 葉輝信, 張錫流, 歐海燕, 等. 上皮鈣黏蛋白和連環(huán)蛋白120在鼻咽癌組織中的表達及相關(guān)性研究 [J]. 臨床耳鼻咽喉頭頸外科雜志, 2009, 23(14): 646648.
  51. 51. 歐海玲, 覃宇周, 張錫流, 等. P120連環(huán)蛋白在鼻咽癌中的表達及其與細胞凋亡的關(guān)系 [J]. 實用醫(yī)學(xué)雜志, 2009, 25(22): 37493752.
  52. 52. Zhang X, Disanto ME. Rhokinase, a common final path of various contractile bladder and ureter stimuli [J]. Handb Exp Pharmacol, 2011, (202): 543568.
  53. 53. Mandeville JA, Silva Neto B, Vanni AJ, et al. Pcadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells [J]. BJU Int, 2008, 2(11): 17071714.
  54. 54. 林成楚, 許恩賜. 膀胱移行細胞癌中p120ctn的表達及意義 [J]. 山東醫(yī)藥, 2008, 48(30): 3637.
  55. 55. Silva Neto B, Smith GL, Mandeville JA, et al. Prognostic significance of altered p120 ctn expression in bladder cancer [J]. BJU Int, 2008, 101(6): 746752.
  56. 56. 張錫流, 何仕遠, 張力, 等． E鈣黏附蛋白及其相關(guān)蛋白在前列腺癌組織中的表達及其臨床意義 [J]. 檢驗醫(yī)學(xué), 2006, 21(1): 57.
  57. 57. Kaulfuss S, von Hardenberg S, Schweyer S, et al. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression [J]. Oncogene, 2009, 28(45): 39713982.
  58. 58. van Oort IM, Tomita K, van Bokhoven A, et al. The prognostic value of Ecadherin and the cadherinassociated molecules alpha, beta, gammacatenin and p120ctn in prostate cancer specific survival: a longterm followup study [J]. Prostate, 2007, 67(13): 14321438.
  59. 59. Kallakury BV, Sheehan CE, WinnDeen E, et al. Decreased expression of catenins (alpha and beta), p120 CTN, and Ecadherin cell adhesion proteins and Ecadherin gene promoter methylation in prostatic adenocarcinomas [J]. Cancer, 2001, 92(11): 27862795.
  60. 60. Freeman JW, McGrath P, Bondada V, et al. Prognostic significance of proliferation associated nucleolar antigen p120 in human breast carcinoma [J].Cancer Res, 1991, 51(8): 19731978.
  61. 61. Paredes J, Correia AL, Ribeiro AS, et al. Expression of p120catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines [J]. Cell Oncol, 2007, 29(6): 467476.
  62. 62. Sarrió D, PérezMies B, Hardisson D, et al. Cytoplasmic localization of p120ctn and Ecadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions [J]. Oncogene, 2004, 23(19): 32723283.
  63. 63. Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin [J]. Am J Surg Pathol, 2007, 31(3): 427437.
  64. 64. 李曉鳴, 溫漓潮, 朱任之. 乳腺典型髓樣癌與非典型髓樣癌生物學(xué)行為差異的研究 [J]. 中國普外基礎(chǔ)與臨床雜志, 2003, 10(3): 268269.
  65. 65. Boriani S, Bandiera S, Biagini R, et al. Chordoma of the mobilesp ine: fifty years of experience [J]. Spine (Phila Pa 1976), 2006, 31(4): 493503.
  66. 66. Guirat A, Affes N, Boujlbene S, et al. Sacral chordoma: a rare tumor of the buttocks [J]. Ann Dermatol Venereol, 2009, 136(67): 526529.
  67. 67. Schwab JH, Boland PJ, Agaram NP, et al. Chordoma and chondrosarcoma gene profile: implications for immunotherapy [J]. Cancer Immunol Immunother, 2009, 58(3): 339349.
  68. 68. 馬俊明, 楊興海, 黃權(quán), 等. Ecadherin和P120ctn在脊柱脊索瘤中的異常表達 [J]. 脊柱外科雜志, 2009, 7(4): 193197.
  69. 69. Chartier NT, Oddou CI, Lainé MG, et al. Cyclindependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)dependent cell growth control: a new role for p120ctn in cancer [J]. Cancer Res, 2007, 67(20): 97819790.